We investigated the effect of the phenylalkylamine Ca 2؉ ؉ channel inhibitor verapamil on voltage-dependent K ؉ ؉ (Kv) channels in rabbit coronary arterial smooth muscle cells using a whole-cell patch clamp technique. Verapamil reduced the Kv current amplitude in a concentration-depenent manner. The apparent K d value for Kv channel inhibition was 0.82 m mM. Although verapamil had no effect on the activation kinetics, it accelerated the decay rate of Kv channel inactivation. The rate constants of association and dissociation by verapamil were 2.20؎ ؎0.02 m mM ؊ ؊1 s ؊ ؊1
Influx via voltage-dependent Ca 2ϩ channels is the one of the major mechanisms of Ca 2ϩ influx for the initiation of vascular smooth muscle contraction. [1] [2] [3] Ca 2ϩ channel blockers inhibit the entry of calcium into cardiac and vascular smooth muscle cells via voltage-dependent L-type Ca 2ϩ channels, which results in the relaxation of vascular smooth muscle and prevention of coronary vasospasm. [4] [5] [6] Several Ca 2ϩ channel blockers are used therapeutically in the management of hypertension as monotherapy or in combination with other antihypertensive agents. 7, 8) Phenylalkylamine Ca 2ϩ channel inhibitor verapamil has been used in the treatment of hypertension, cardiac arrhythmia, and coronary vasospasm, and is effective in angina pectoris. 9, 10) However, the unexpected effects of verapamil on other channels limit its safe use. 11, 12) Vascular smooth muscles express four types of K ϩ channels: voltage-dependent K ϩ (Kv), Ca 2ϩ -activated K ϩ (BK Ca ), ATP-sensitive K ϩ (K ATP ), and inward rectifier K ϩ (Kir) channels. 13) Among these channels, Kv channel contributes to the regulation of membrane potential, and thereby basal tone, and agonist-induced changes in vascular diameter. [13] [14] [15] [16] [17] Therefore, it is important to examine the effect of verapamil and its mechanism of action on Kv channels to avoid unexpected consequences in vascular smooth muscle.
In the present study, we clarified the effect of verapamil on Kv channels and determined its detailed mechanism of action by a patch clamp technique in native coronary arterial smooth muscle cells. Here, we show that verapamil directly inhibited Kv channels in a state-, time-, and use-dependent manner.
MATERIALS AND METHODS
Cell Isolation New Zealand White rabbits (2.0-2.3 kg) of either sex were sacrificed with sodium pentobarbitone (50 mg/kg) and heparin (100 U/kg), which were injected simultaneously into the ear vein. The rabbit for the experiments was approved by the Institutional Animal Care and Use Committee (IACUC) of the Inje University, Korea. The hearts were removed, and the left anterior descending coronary artery was rapidly dissected and cleaned of connective tissue under a stereomicroscope. Single vascular smooth muscle cells were mechanically dispersed by triturating the arteries after two step enzyme treatment with papain (1 mg/ml) and collagenese (1.5 mg/ml) in Ca 2ϩ -free normal Tyrode solution as described previously. 18) Cells were kept at 4°C under Kraft-Brühe (KB) and used within the same day. KB solution contained (in mM): 70 KOH, 50 L-glutamate, 20 KH 2 PO 4 , 55 KCl, 20 taurine, 3 MgCl 2 , 20 glucose, 10 N-(2-hydroxyethyl)piperazine-N Ј-2-ethanesulfonic acid (HEPES), 0.5 EGTA adjusted to pH 7.3 with KOH.
Electrophysiological Recordings Whole cell K ϩ currents were recorded with patch-clamp technique using Axopatch 1C amplifier (Axon instruments, Union, CA, U.S.A.) and a DigiData 1322 interface (Molecular Devices, Sunnyvale, CA, U.S.A.). The patch pipettes were fabricated on a model PP-83 vertical puller (Narishige, Tokyo, Japan). The currents were filtered at 1-2 kHz and digitized at 2-4 kHz. The resistance of patch pipettes was 3-4 MW with filling of the pipette solution.
The extracellular solution for whole cell recording was As described previously, 19) the drug-channel interaction kinetics could be expressed with a first-order blocking scheme. The affinity constant (K d ) and Hill coefficient (n), which were obtained from data on concentration-dependence, were determined by the Hill equation:
where f is the fractional current block ( fϭ1ϪI drug /I control ) at the test potential, and [D] is the concentration of the drug. The activation curve was determined from tail currents elicited on return to Ϫ40 mV after depolarizing voltage from Ϫ60 to ϩ80 mV in 10 mV increments. Activation curves were fit with the Boltzmann equation, as follows:
where V represents the test potential, V 1/2 is the mid-point of activation and k is the slope factor.
The steady-state inactivation was studied using a twopulse voltage protocol; currents were measured at ϩ40 mV, and the 7 s pre-pulses to potential varied from Ϫ70 to ϩ40 mV in steps of 10 mV. The curves for steady-state inactivation were fit with the Boltzmann equation:
where V represents the test potential, V 1/2 is the mid-point potential, and k is the slope factor of the curve. Figure 1 shows the effect of verapamil on the Kv currents recorded with step-depolarizing pulses from Ϫ80 to ϩ60 mV and a holding potential of Ϫ60 mV. The Kv current was rapidly inhibited by 3 mM verapamil within 1 min, and this inhibitory effect was completely abrogated by washout (data not shown). Figures 1C and D show the current-voltage (I-V) relationships of peak and steady-state Kv currents in the absence and presence of 3 mM verapamil, respectively. Verapamil reduced the both peak and steady-state current, but the extent of the reduction in the steady-state current was much more prominent than that in the peak current.
RESULTS

Inhibition of Kv Current by Verapamil
Verapamil Inhibits Kv Currents in a Dose-Dependent Manner Figure 2 shows representative Kv currents superimposed on the variable concentration of verapamil at 0.3, 1, 3, 10, and 30 mM to evaluate dose-dependency. The Kv currents were recorded by depolarizing pulses to ϩ60 mV from a holding potential of Ϫ60 mV. As described in Fig. 1 , Kv current inhibition by verapamil was greater for the steadystate current than for the peak current. For steady-state inhibition, a nonlinear least-squares fit of the Hill equation to the concentration-response data at ϩ60 mV yielded a K d value of 0.82Ϯ0.03 mM and a Hill coefficient of 1.10Ϯ0.04 (Fig.  2B) .
Kinetics of Kv Current Inhibition by Verapamil
To evaluate the effects of verapamil on the activation time constant, the rising phase of each trace was measured by fitting a 48 Vol. 33, No. 1
Fig. 1. Effects of Verapamil on Kv Channels from Coronary Arterial Smooth Muscle Cells
The Kv currents were elicited by a 600 ms depolarizing pulse from Ϫ80 to ϩ60 mV in increments of 10 mV at a holding potential of Ϫ60 mV. Representative Kv currents without (A) and with (B) 3 mM verapamil. I-V relationship of the peak (C) and steady-state (D) Kv currents in the absence (᭺) and presence (᭹) of verapamil. nϭ5. * pϽ0.05. monoexponential curve at ϩ60 mV under additive increases in the concentration of verapamil. The time constants for activation of the Kv current were 11.98Ϯ0.15 (nϭ5) and 12.21Ϯ0.19 (nϭ4) ms in the absence and presence of 3 mM verapamil, respectively. These results suggest that the activation process was not significantly altered by verapamil. However, Fig. 2A shows that the decay rate of the Kv current accelerated significantly with increases in the concentration of varapamil. In the Kv current with verapamil treatment, the inactivation processes were composed of fast and slow components. The slow component is regarded as an intrinsic inactivation process in vascular smooth muscle. 17) Therefore, the fast component was thought to represent the time constant for drug-induced blockade of the Kv current (t D ). 
Effects of Verapamil on the Activation and SteadyState Inactivation of the Kv Current
The activation and inactivation curves were measured in the absence and presence of 3 mM verapamil to investigate whether the inhibition was due to a shift in the activation and inactivation curves. The activation curves were obtained using the tail current with a typical two-pulse protocol in the absence and presence of verapamil. The application of verapamil did not affect steady-state activation with a voltage of half-maximal activation potential (V 1/2 ) and slope value (k) of Ϫ13.58Ϯ0.67 mV and 8.60Ϯ0.52, respectively, for the control and Ϫ13.70Ϯ 0.63 mV and 7.97Ϯ0.33, with verapamil (Fig. 4A) .
The steady-state inactivation of Kv was investigated using a typical two-pulse protocol in the absence and presence of verapamil. The inactivation curve of Kv current was not changed by verapamil; the potential of half-maximal activation (V 1/2 ) and the slope value (k) were Ϫ34.68Ϯ0.51 mV and 9.33Ϯ0.40, respectively, under control conditions and Ϫ35.26Ϯ0.50 mV and 8.90Ϯ0.44, respectively, in the presence of verapamil (Fig. 4B) . The lack of an effect on steadystate inactivation may be explained as an inability of verapamil to interact with the channel in the inactivated state.
Use-Dependent and Recovery Kinetics of Kv To evaluate the use-dependent inhibition of Kv by verapamil, we recorded the Kv current at two different frequencies, 1 Hz and 2 Hz, in the absence and presence of verapamil (3 mM, Fig. 5 ). Under control conditions, the Kv currents were slightly reduced by the both 1 Hz and 2 Hz stimulation. For example, the peak amplitude of the Kv current measured after a train of 20 depolarizing pulses was decreased by 14% at a frequency of 1 Hz and by 22% at a frequency of 2 Hz in the absence of verapamil. However, in the presence of verapamil, the Kv current showed greater decay than the control until it reached a steady-state block. For example, the peak amplitude of the Kv current after 20 depolarizing pulses was reduced by 53.20Ϯ0.64% at 1 Hz and by 39.35Ϯ0.31% at 2 Hz in the presence of verapamil. These results suggested that the recovery of the channel blocked by verapamil was slower than that of the control. To explain this result more clearly, we investigated the recovery time from inactivation using a double-pulse protocol in which the interpulse interval was varied from 20 to 7000 ms. Figure 6 shows the representative curves, which were fit with a single exponential, in 
Fig. 3. Time Constant of Inhibition as a Function of the Drug Concentration
Time constants (t D ) were estimated from single exponential fits to the decay phase of the tracings shown in Fig. 2A . The time courses of the current during inactivation were fit to a single (control) or double (presence of verapamil) exponential function. The apparent rate constants for association (k ϩ1 ) and dissociation (k Ϫ1 ) were obtained from 
DISCUSSION
The results of the present study indicated that verapamil affects Kv channels, and its mechanism of action was determined in rabbit coronary arterial smooth muscle cells. The main findings of this study were that verapamil inhibits Kv channels in a state-, time-, and use-dependent manner. In addition, the inhibition of Kv channels by verapamil had no effect on the voltage-dependent activation and inactivation curves.
Several observations indicated that the inhibitory effect of verapamil on Kv channels was not mediated by the inhibition of Ca 2ϩ channel but was the result of direct action on Kv channels. (1) Another Ca 2ϩ channel inhibitor, nifedipine, had no effect on the Kv channels and did not alter the inhibitory effect of verapamil. Furthermore, the deletion of extracellular Ca 2ϩ did not alter the inhibitory effect of verapamil (Fig.  7) . (2) The inhibitory time course of verapamil is very short, reaching the steady-state inhibition of Kv channels within 1 min. Therefore, the inhibitory effect of verapamil on Kv channels did not involve Kv-related signaling mechanisms, but was the result of its direct action.
The inhibitory effect of verapamil on Kv channels is most likely due to an interaction in the open state. Figures 2 and 3 suggest that the time course of the Kv current was accelerated by verapamil in a concentration-dependent manner, even though the activation time course was not changed. Furthermore, the peak amplitude of the Kv current was affected rel- Twenty repetitive depolarizing pulses from Ϫ60 to ϩ40 mV for 150-ms each were applied in the absence (᭺, ᮀ) and presence of verapamil (᭹, ) at frequencies of 1 Hz and 2 Hz. Each peak current obtained at by frequencies of 1 Hz or 2 Hz was normalized to the peak current at the first pulse and then plotted against the number of pulses. nϭ4.
Fig. 6. Effects of Verapamil on the Kinetics of Kv Recovery from SteadyState Inactivation
The degree of recovery was measured by following a double-pulse protocol; the first pre-pulse of a 150-ms depolarizing potential of ϩ40 mV from a holding potential of Ϫ60 mV was followed by a second identical pulse after increasing time intervals between 20 ms and 7000 ms (inset). All cycles of the double-pulse protocol were 10 s. The peak currents elicited by the second test pulse were normalized against the peak currents obtained by the first pre-pulse and plotted as a function of the various interpulse intervals. The solid line represents the recovery kinetics of Kv current in the absence (᭺) and presence of verapamil (᭹). nϭ5. * pϽ0.05.
atively little by verapamil at the first onset of depolarization. In addition, verapamil did not alter the activation or steadystate inactivation curves, suggesting that this agent interacts with Kv channels in the open state, and not the inactivated state (Fig. 4) .
A number of classes of Ca 2ϩ channel blockers such as dihydropyridine, phenylalkylamine, and benzothiazepine have been reported to date. Among these, phenylalkylamine was reported to reduce myocardial oxygen demand, and coronary vasospasm. Phenylalkylamine is also very effective in the treatment of angina pectoris. 23) Verapamil, which is a specific phenylalkylamine Ca 2ϩ channel inhibitor, causes vasodilation and in turn lowers arterial blood pressure. However, effects of verapamil on other channels have also been reported. For example, verapamil was shown to inhibit ultra-rapid delayed rectifier K ϩ current in human atrial myocytes, 24) delayed rectifier K ϩ currents in guinea pig cardiac myocytes, 25) the human Ether-á-go-go Related Gene (HERG) K ϩ channels expressed in HEK 293 cells, 26) rapidly activating delayed rectifier K ϩ channels in cloned human heart cells 11) and largeconductance Ca 2ϩ -activated K ϩ channels in rat aortic myocytes. 27 ) Although these reports also, but partially, explained the inhibitory mechanism of verapamil on delayed rectifier K ϩ channel, the data were originated from cardiac cells, not vascular smooth muscle. Furthermore, verapamil effect on aortic smooth muscle was restricted to large-conductance Ca 2ϩ -activated K ϩ channels. In this reason, neither the effect of verapamil nor its mechanism of action on Kv channels from native coronary arterial smooth muscle cells has been determined, even though verapamil has been used as an inhibitor of Ca 2ϩ channels. Considering its clinical relevance, the identification of unexpected effects of verapamil on other types of channel is necessary in order to avoid misinterpretation of data.
The Kv channel expressed in coronary vascular smooth muscle is one of the major channels involved in the regulation of the resting membrane potential, and it also mediate the physiological changes in agonist-induced vascular tone. 3, 22, 28) Therefore, elucidation of unexpected effects of chemical agents on Kv channels is an important area of research. Indeed, several previous studies have revealed unexpected effects of various agents on Kv channels. For example, the protein kinase C (PKC) inhibitors staurosporine and bisindolylmaleimide(I) were shown to directly inhibit Kv channels in the coronary artery, mesenteric artery, and cell lines stably expressing Kv subtypes. 17, 21, 22, 29, 30) The protein kinase A (PKA) inhibitor H-89 and the tyrosine kinase inhibitor genistein also inhibited Kv channels in rabbit coronary arterial smooth muscle cells. 31, 32) Together with the results of previous studies, the findings presented here provide information that will be important when using these agents to study Kv channels.
The Kv currents can be classified as the delayed rectifier outward K ϩ current (I K ) and transient outward K ϩ current (I A ) based on the differences in the voltage dependence of activation and/or inactivation, and pharmacological properties in vascular smooth muscle cells. 15, 33) The I K showed a relatively slow activation and inactivation kinetics in comparison to the I A . 34, 35) Although the detailed molecular subtypes of Kv channel remains to be determined in vascular smooth muscle, at least, it has been known that Kv1.2, Kv1.5 and Kv2.1 alpha subunits were regarded as main subtypes of I K since these subtypes showed the similar current kinetics to the native I K in vascular smooth muscle cells. 36, 37) Therefore, we suggest that verapamil may inhibit Kv1.2, Kv1.5 and/or Kv2.1 subtypes in native coronary arterial smooth muscle cells. To make a clear, it needs to further experiment whether verapamil inhibits Kv current using the overexpressed HEK-293 cells with Kv1.5 (Kv1.2 or Kv2.1) subtype or whether knock down of Kv1.5 (Kv1.2 or Kv2.1) using siRNA can abolish the verapamil effect in coronary arterial smooth muscle cells. In the present study, we found that verapamil directly inhibits the Kv current of smooth muscle cells from rabbit coronary artery in a state-, time-, and use-dependent manner. Furthermore, the inhibitory effects of verapamil are completely independent of Ca 2ϩ channel inhibition. Therefore, caution is required when using verapamil to inhibit Ca 2ϩ channels in the vascular system.
